Square Pharmaceutical board of directors has recommended 120 per cent cash dividend for the year ended June 30, 2025.
The board also approved Tk 650 crore for BMRE, capital machineries, and lands for future expansion.
The date of AGM is December 15 and the record date is November 16, according to a DSE report.聽